rituximab (Rituxan) to be used in combination with methotrexate for rheumatoid arthritis

Health Canada now approves rituximab (Rituxan) to be used in combination with methotrexate for rheumatoid arthritis.

Rheumatoid arthritis affects 1 out of every 100 Canadians.

Researchers believe cells that produce antibodies play a key role in the inflammation and progression of rheumatoid arthritis. These are B-cells. Rituximab selectively targets B-cells...allowing the immune system to recognize and eliminate them.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote